Literature DB >> 11155039

Formation, inhibition and clearance of plasmin in vivo.

W L Chandler1, M C Alessi, M F Aillaud, P Vague, I Juhan-Vague.   

Abstract

A 5 microg/kg bolus of tissue plasminogen activator (t-PA) was infused into 11 healthy subjects followed by measurement of t-PA activity and antigen, PAI-1 activity and antigen, t-PA/PAI-1 complex, plasmin/antiplasmin (PAP) complex and D-dimer over 4 h. Infusion of t-PA resulted in a rise in PAP levels in all subjects from a baseline of 2.4 +/- 1.1 nmol/l to a peak of 5.1 +/- 2.3 nmol/l, but had no effect on plasminogen, antiplasmin or D-dimer levels. Using a kinetic model of plasminogen activation in vivo, the second-order rate constant for t-PA binding to plasminogen was estimated to be 3,100 +/- 1,300 mol(-1)l x s(-1), 200-500 times slower than t-PA accelerated by fibrin. The half-life of PAP was 4.5 +/- 1.6 h. In healthy subjects, the PAP level in plasma represents the average rate of plasminogen activation over the last 2-8 h.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11155039     DOI: 10.1159/000054136

Source DB:  PubMed          Journal:  Haemostasis        ISSN: 0301-0147


  10 in total

1.  Human Kunitz-type protease inhibitor engineered for enhanced matrix retention extends longevity of fibrin biomaterials.

Authors:  Priscilla S Briquez; Kristen M Lorentz; Hans M Larsson; Peter Frey; Jeffrey A Hubbell
Journal:  Biomaterials       Date:  2017-04-29       Impact factor: 12.479

Review 2.  Advances in the understanding of trauma-induced coagulopathy.

Authors:  Ronald Chang; Jessica C Cardenas; Charles E Wade; John B Holcomb
Journal:  Blood       Date:  2016-07-05       Impact factor: 22.113

3.  tPA receptors and the fibrinolytic response in multiple sclerosis lesions.

Authors:  Djordje Gveric; Blanca M Herrera; M Louise Cuzner
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

4.  SMTP (Stachybotrys microspora triprenyl phenol) enhances clot clearance in a pulmonary embolism model in rats.

Authors:  Weimin Hu; Ritsuko Narasaki; Naoko Nishimura; Keiji Hasumi
Journal:  Thromb J       Date:  2012-01-09

5.  Fibrinolytic system activation immediately following trauma was quickly and intensely suppressed in a rat model of severe blunt trauma.

Authors:  Mineji Hayakawa; Takumi Tsuchida; Yoshinori Honma; Asumi Mizugaki; Takayoshi Ooyasu; Tomonao Yoshida; Tomoyo Saito; Kenichi Katabami; Takeshi Wada; Kunihiko Maekawa
Journal:  Sci Rep       Date:  2021-10-13       Impact factor: 4.379

6.  Analysis of CSF D-Dimer to Identify Intrathecal Fibrin-Driven Autoimmunity in Patients With Multiple Sclerosis.

Authors:  Martin A Schaller-Paule; Yavor Yalachkov; Helmuth Steinmetz; Lucie Friedauer; Elke Hattingen; Wolfgang Miesbach; Frank Weber; Konstantin Kirchmayr; Jan Hendrik Schaefer; Christian Foerch
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2022-03-08

7.  Filgrastim, fibrinolysis, and neovascularization.

Authors:  Darwin Eton; Guolin Zhou; Tong-Chuan He; Amelia Bartholomew; Rachana Patil
Journal:  J Tissue Eng Regen Med       Date:  2022-02-17       Impact factor: 4.323

8.  Therapeutic use of α2-antiplasmin as an antifibrinolytic and hemostatic agent in surgery and regenerative medicine.

Authors:  Jialu Liu; Ani Solanki; Michael J V White; Jeffrey A Hubbell; Priscilla S Briquez
Journal:  NPJ Regen Med       Date:  2022-06-30

9.  Label-Free Kinetic Studies of Hemostasis-Related Biomarkers Including D-Dimer Using Autologous Serum Transfusion.

Authors:  Heiko Rühl; Christina Berens; Anna Winterhagen; Jens Müller; Johannes Oldenburg; Bernd Pötzsch
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

10.  Fibrinolysis and COVID-19: A tale of two sites?

Authors:  Charithani B Keragala; Robert L Medcalf; Paul S Myles
Journal:  J Thromb Haemost       Date:  2020-09       Impact factor: 16.036

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.